The table below shows Black Diamond Therapeutics, Inc.'s income statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
Line item
Q1 2026
Q3 2025
Q2 2025
Q1 2025
Q3 2024
Q2 2024
Revenue
$0.00
$0.00
$0.00
$70.00M
$0.00
$0.00
Cost of revenue
-
-
-
-
-
-
Gross profit
-
-
-
-
-
-
R&D
$7.00M
$7.44M
$9.32M
$10.51M
$12.91M
$12.56M
SG&A
BDTX annual revenue (10-K history)
Black Diamond Therapeutics, Inc. reported annual revenue of $70.00M for fiscal year 2025. Figures come from the company's audited annual reports as filed with the SEC.